How does adalimumab work?

Adalimumab (Adalimumab) is a humanized monoclonal antibody, a biologic drug that mainly exerts its therapeutic effect by targeting tumor necrosis factor-α (TNF-α). TNF-α is a key cytokine in the immune system. It is widely involved in a variety of inflammatory reactions and is one of the main causative factors of many autoimmune diseases. In diseases such as rheumatoid arthritis (RA), psoriasis, and Crohn's disease, excessive TNF-α activity can lead to abnormal immune system responses, leading to inflammation, tissue damage, and organ dysfunction.

The principle of action of adalimumab is to block the binding of TNF-α to its receptor and inhibit the activity of TNF-α by binding to TNF-α molecule. This effect can reduce the immune system's attack on normal tissues, alleviate disease symptoms, and improve patients' quality of life. By inhibiting TNF-α, adalimumab can effectively reduce the inflammatory response caused by immune system abnormalities and slow down the progression of the disease. Especially in patients with rheumatoid arthritis, it can significantly reduce joint inflammation and slow down joint damage.

The effects of adalimumab are not limited to simple anti-inflammatory effects. Due to the multiple roles ofTNF-α in immune responses, adalimumab can also regulate the function of the immune system and reduce excessive immune responses. For patients with inflammatory bowel diseases such as Crohn's disease, adalimumab helps restore the intestinal barrier function by inhibiting the intestinal inflammatory response, relieves the disease, and reduces the recurrence of the disease.

In general, adalimumab achieves the effect of treating immune system-related diseases by targetingTNF-α and blocking its excessive activation of the immune system. Its precise mechanism of action enables it to show significant efficacy in the treatment of rheumatoid arthritis, psoriasis, Crohn's disease and other diseases, making it one of the important drug choices in clinical treatment.

Reference materials:https://www.drugs.com/adalimumab.html